Neuralink, Elon Musk's brain implant venture, is reaching out to major U.S. neurosurgery centers to potentially begin testing its devices on humans, according to a Reuters report. Before that can happen though, the U.S. government needs to grant the company approval, which is far from certain. In 2022, the U.S. Food and Drug Administration rejected its application to proceed with human trials due to safety concerns. Neuralink has been working to address those concerns ever since. 

Share:
More In Science
Supreme Court Set to Decide on Abortion Pill Access
The Supreme Court is facing a self-imposed Friday night deadline to decide whether women’s access to a widely used abortion pill will stay unchanged until a legal challenge to its Food and Drug Administration approval is resolved.
How Fast Fashion Is Hurting the Environment
Earth Day is in just a few days, and Shelley Rogers, who coordinates a fashion initiative for Earthday.org, stopped by the Cheddar News studios to showcase some clothing options for environmentally-conscious shoppers.
Load More